SwordCath® without Guidewire for low Complexity
(under development)

SwordCath® without Guidewire for low Complexity
(under development)

No guidewire
All components integrated
For maximum hygienic, safe and quick handling
Previous slide
Next slide

Under development, not yet for patient use. For multiple future benefits and highly relevant study endpoints. A positive correlation between technical features and beneficial outcomes has to be shown.

Extensive IP Portfolio

3328478 (EU, Granted)
19704221.1 (EU, Accepted)
10,806,902 (US, Granted)
16/966,546 (US, Accepted)
201980010557.4 (China, Granted)
2016299343 (Australia, Granted)
112018001895-3 (Brazil, Granted)
201817003681 (India, Granted)
PCT/EP2016/067785 (PCT)          PCT/EP2019/051751 (PCT)

17/018,285 (US, Pending)
201680044512.5 (China, Pending)
2019215680 (Australia, Pending)
BR112020015371-0 (Brazil, Pending)
3,030,977 (Canada, Pending)
202037034867 (India, Pending)
2020-540538 (Japan, Pending)
2021-044347 (Japan, Pending)
10-2020-7024971 (South Korea, Pending)
10-2018-7005633 (South Korea, Pending)

3328478 (EU, Granted)
19704221.1 (EU, Accepted)
10,806,902 (US, Granted)
16/966,546 (US, Accepted)
201980010557.4 (China, Granted)
2016299343 (Australia, Granted)
112018001895-3 (Brazil, Granted)
201817003681 (India, Granted)
PCT/EP2016/067785 (PCT)
PCT/EP2019/051751 (PCT)

17/018,285 (US, Pending)
201680044512.5 (China, Pending)
2019215680 (Australia, Pending)
BR112020015371-0 (Brazil, Pending)
3,030,977 (Canada, Pending)
202037034867 (India, Pending)
2020-540538 (Japan, Pending)
2021-044347 (Japan, Pending)
10-2020-7024971 (South Korea, Pending)
10-2018-7005633 (South Korea, Pending)